CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.
September 20th 2023
Nine years of Pinktober while living with metastatic breast cancer.
Popular Heart Medications May Curb Cardiac Toxicity in Patients With Breast Cancer
March 15th 2018Findings from a new study presented at the American College of Cardiology’s 67th Annual Scientific Session showed that adding two popular heart medications to the chemotherapy regimen may prevent heart damage from happening in these patients.
FDA Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer
February 27th 2018The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.
Patients Concerned as Humana Takes Herceptin Off Preferred Drug List in South Florida
January 30th 2018Until recently, Herceptin, which is used to treat patients with metastatic breast cancer, was fully covered under Humana’s South Florida Medicare Advantage plans. But, after taking it off the preferred drug list, patients will now be responsible for 20 percent of the drug’s cost, better aligning South Florida’s plans with Humana’s other Medicare Advantage plans.
FDA Approves Lynparza for BRCA-Positive Breast Cancer
January 12th 2018Lynparza (olaparib) was granted approval by the Food and Drug Administration (FDA) for the treatment of patients with BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy. Also, patients who have HR-positive disease should have prior endocrine therapy or they would not be considered appropriate for such treatment.